QNCX Stock Summary and Trading Ideas (Quince Therapeutics | NASDAQ:QNCX)

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Quince Therapeutics trades on the NASDAQ stock market under the symbol QNCX.

As of April 16, 2026, QNCX stock price climbed to $1.34 with 2,587,025 million shares trading.

QNCX has a beta of 0.68, meaning it tends to be less sensitive to market movements. QNCX has a correlation of 0.00 to the broad based SPY ETF.

QNCX has a market cap of $21.84 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, QNCX traded as high as $45.50 and as low as $.80.

The top ETF exchange traded funds that QNCX belongs to (by Net Assets): VXF, IWC.

QNCX has underperformed the market in the last year with a return of -86.6%, while the SPY ETF gained +34.9%. In the last 3 month period, QNCX fell short of the market, returning -96.2%, while SPY returned +1.7%. However, in the most recent 2 weeks QNCX has outperformed the stock market by returning +35.4%, while SPY returned +7.0%.

QNCX support price is $1.02 and resistance is $1.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNCX shares will trade within this expected range on the day.